Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (1): 80-84    DOI: 10.31083/j.ejgo.2020.01.5093
Original Research Previous articles | Next articles
Development of high-risk HPV associated cervical dysplasia despite HPV-vaccination: a regional dysplasia center cohort study
A.K. Fischer1, K. Reuter-Jessen2, H.-U. Schildhaus2, T. Hugo2, A.H. Scheel3, S. Merkelbach-Bruse3, E. Heinmöller1, R. Buettner3, B. Jasani4, J. Walbeck5, J.Rüschoff1, 4, *(), P. Middel1
1 Institute of Pathology Nordhessen, Kassel, Germany
2 Institute of Pathology, University Hospital Göttingen, Göttingen, Germany
3 Institute of Pathology, University Hospital Cologne, Cologne, Germany
4 Targos Molecular Pathology GmbH, Kassel, Germany
5 Regional Dysplasia Clinic Nordhessen, Kassel, Germany
Download:  PDF(1928KB)  ( 357 ) Full text   ( 6 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
The present study was conducted to examine the frequency of CIN/squamous intraepithelial lesions in patients after vaccination and respective HPV types observed at their referral to a regional center for screening of cervical dysplasia.
Key words:  HPV      Vaccination      Cervical intraepithelial neoplasia     
Published:  15 February 2020     
*Corresponding Author(s):  J. RÜSCHOFF     E-mail:  info@patho-nordhessen.de

Cite this article: 

A.K. Fischer, K. Reuter-Jessen, H.-U. Schildhaus, T. Hugo, A.H. Scheel, S. Merkelbach-Bruse, E. Heinmöller, R. Buettner, B. Jasani, J. Walbeck, J.Rüschoff, P. Middel. Development of high-risk HPV associated cervical dysplasia despite HPV-vaccination: a regional dysplasia center cohort study. European Journal of Gynaecological Oncology, 2020, 41(1): 80-84.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.01.5093     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I1/80

[1] Qunying Wu, Jin-Ho Kuk, Young-Joon Ryu. A Distinct Human Papilloma Virus Epidemiological Profile of Korean-Chinese Women Living in Yanbian, China[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 753-761.
[2] Behiye Pinar Goksedef, Burak Giray, Canan Kabaca, Murat Ekmez, Sinan Gulec, Esra Keles, Isa Aykut Ozdemir, Suleyman Salman, Derya Sivri Aydin. Utility of colposcopy in the management of ASCUS and LSIL in women younger than 25-year-old: A retrospective multicenter study[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 685-688.
[3] Panteleimon Mnimatidis, Abraham Pouliakis, George Valasoulis, George Michail, Aris Spathis, Christine Cottaridi, Niki Margari, Maria Kyrgiou, Maria Nasioutziki, Alexandros Daponte, Konstantinos Dinas, Evangelos Paraskevaidis, Ioannis Panayiotides, Dimitrios-Dionysios Koutsouris. Multicentric assessment of cervical HPV infection co-factors in a large cohort of Greek women[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 545-555.
[4] Selçuk Kaplan. The role of p16 / Ki-67 dual staining in HPV positive and negative women in the early diagnosis of cervical precancerous lesions: Cytology, colposcopy and conization protocol[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 569-576.
[5] I. Ferreira, C. Estevinho, A. Torgal, C. Carrapatoso, F. Costa. Should we search for high-risk HPV in vaginal vault Pap smear after hysterectomy due to CIN2+?[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 157-162.
[6] Ö. Demir, A. C. İyibozkurt, İ. Kalelioğlu, S. Topuz, S. Berkman. Performance of multimodal hyperspectroscopy for scanning of cervix in pregnant women: a preliminary study[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 277-280.
[7] C. Chiappetta, C. Puggioni, E. Lendaro, J. Cacciotti, G. Migliore, P. Bellardini, V. Petrozza, C. Della Rocca, C. Di Cristofano. The hr-HPV based cervical cancer screening: results of a four-years experience in a single screening center of Italy[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 932-938.
[8] J.-H. Kim, D.-Y. Kim. Imiquimod as an alternative option for young women with high-grade cervical intraepithelial neoplasia[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 943-947.
[9] E. Palma, M. Bertini. Vaginal microbiota and the pathobiosis path: its role in the evolution of HPV cervical intraepithelial neoplasia and cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 534-537.
[10] N. Tsagkas, V. Siafaka, A. Tzallas, C. Zerzi, M. Zografou, E. Bilirakis, M. Paraskevaidi, M. Kyrgiou, E. Paraskevaidis. Knowledge and beliefs about HPV infection and the relevant vaccination in Greek young population[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 557-562.
[11] P. Ortega-Quiñonero, M. Remezal-Solano, M.C. Carazo-Díaz, D. Prieto-Merino, M.I. Urbano-Reyes, L. García de Guadiana-Romualdo, J.P. Martínez-Cendán. Impact of the human papillomavirus vaccination on patients who underwent conization for high-grade cervical intraepithelial neoplasia[J]. European Journal of Gynaecological Oncology, 2019, 40(3): 402-407.
[12] S.M.S. Fernandes, J.C.L. Ribalta, N.M.G. Speck, Y. Yamamura. Oncology cytology and HPV DNA testing in women with cervical ectopy[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 232-235.
[13] F. Liu, D.H. Hu, M.J. Fei, Y.F. Zhang, B. Wang, C.Y. Wang, K. Huang. Evaluation of p16/Ki67 dual staining compared with high-risk HPV testing to assess liquid-based cytology with atypical squamous cells of unknown significance[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 249-253.
[14] Aiping Fan, Chen Wang, Liqin Zhang, Ye Yan, Yingmei Wang, Cha Han, Fengxia Xue. The effect of different cervical transformation zone types on the colposcopic diagnosis of cervical intraepithelial neoplasia[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 290-294.
[15] R.J. Martinez-Portilla, M. Rial-Crestelo, M.A. Mejia-Ugarte, J.L. Lopez-Velazquez. Risk of cervical cancer and squamous intraepithelial lesions according to human papillomavirus high-risk serotypes detected by qualitative real-time in vitro PCR[J]. European Journal of Gynaecological Oncology, 2019, 40(1): 19-22.
No Suggested Reading articles found!